Company record
Sambrosa Care Inc.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Sambrosa Care Inc..
Warning letters
-
DrugsSambrosa Care Inc.
FDA warns Sambrosa Care that its OTC sweet dreams Night Syrup is an unapproved, misbranded drug with excessive doxylamine dosing.
High risk